Roles and regulation of the transcription factor CREB in pancreatic β-cells

Current Molecular Pharmacology

Volumn 4, Issue 3, 2011, Pages 187-195

  Dalle, Stéphane ^a,b   Quoyer, Julie ^a,b,c   Varin, Elodie ^a,b   Costes, Safia ^d  

^a INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

^b UNIV MONTPELLIER   (France)

^c INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; CREB; Insulin secretion; Pancreatic cell; Signalling pathways; Type 2 diabetes

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; G PROTEIN COUPLED RECEPTOR; TYROSINE KINASE RECEPTOR;

CELL SURVIVAL; GLUCOSE TRANSPORT; HUMAN; INTRACELLULAR SIGNALING; MOLECULAR INTERACTION; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; SENSITIVITY AND SPECIFICITY;

CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DIABETES MELLITUS, TYPE 2; GLUCOSE; HUMANS; INSULIN; INSULIN-SECRETING CELLS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 80053524655     PISSN: 18744672     EISSN: 18744702     Source Type: Journal    
DOI: 10.2174/1874467211104030187     Document Type: Review

References (73)

1. Del Prato, S.; Tiengo, A. The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitus. Diabetes Metab. Res. Rev., 2001, 17(3), 164-174.
2. Goldfine, A.B.; Bouche, C.; Parker, R.A.; Kim, C.; Kerivan, A.; Soeldner, J.S.; Martin, B.C.; Warram, J.H.; Kahn, C.R. Insulinresistance is a poor predictor of type 2 diabetes in individuals withno family history of disease. Proc. Natl. Acad. Sci. USA, 2003,100(5), 2724-2729.
3. Prentki, M.; Nolan, C.J. Islet beta cell failure in type 2 diabetes. J.Clin. Invest., 2006, 116(7), 1802-1812.
4. Rahier, J.; Guiot, Y.; Goebbels, R.M.; Sempoux, C.; Henquin, J.C. Pancreatic beta-cell mass in European subjects with type 2diabetes. Diabetes Obes. Metab., 2008, 10(Suppl. 4), 32-42.
5. Rhodes, C.J. Type 2 diabetes-a matter of beta-cell life and death?Science, 2005, 307(5708), 380-384.
6. Shaywitz, A.J.; Greenberg, M.E. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu. Rev. Biochem., 1999, 68, 821-861.
7. Hagiwara, M.; Alberts, A.; Brindle, P.; Meinkoth, J.; Feramisco, J.; Deng, T.; Karin, M.; Shenolikar, S.; Montminy, M. Transcriptional attenuation following cAMP induction requires PP-1-mediateddephosphorylation of CREB. Cell, 1992, 70(1), 105-113.
8. Mayr, B.; Montminy, M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell.Biol., 2001, 2(8), 599-609.
9. Wadzinski, B.E.; Wheat, W.H.; Jaspers, S.; Peruski, L.F. Jr.; Lickteig, R.L.; Johnson, G.L.; Klemm, D. J. Nuclear protein phosphatase 2A dephosphorylates protein kinase A-phosphorylated CREB and regulates CREB transcriptional stimulation. Mol. Cell.Biol., 1993, 13(5), 2822-2834.
10. Johannessen, M.; Delghandi, M.P.; Moens, U. What turns CREBon? Cell. Signal., 2004, 16(11), 1211-1227.
11. Johannessen, M.; Delghandi, M.P.; Seternes, O.M.; Johansen, B.; Moens, U. Synergistic activation of CREB-mediated transcriptionby forskolin and phorbol ester requires PKC and depends on the glutamine-rich Q2 transactivation domain. Cell. Signal., 2004,16(10), 1187-1199.
12. Persaud, S.J.; Liu, B.; Sampaio, H.B.; Jones, P.M.; Muller, D.S. Calcium/calmodulin-dependent kinase IV controls glucose-inducedIrs2 expression in mouse beta cells via activation of cAMP response element-binding protein. Diabetologia, 2011, 54(5), 1109-1120.
13. Broca, C.; Quoyer, J.; Costes, S.; Linck, N.; Varrault, A.; Deffayet, P.M.; Bockaert, J.; Dalle, S.; Bertrand, G. beta-Arrestin 1 is required for PAC1 receptor-mediated potentiation of long-lastingERK1/2 activation by glucose in pancreatic beta-cells. J. Biol.Chem., 2009, 284(7), 4332-4342.
14. Costes, S.; Broca, C.; Bertrand, G.; Lajoix, A.D.; Bataille, D.; Bockaert, J.; Dalle, S. ERK1/2 control phosphorylation and protein level of cAMP-responsive element-binding protein: a key role inglucose-mediated pancreatic beta-cell survival. Diabetes, 2006,55(8), 2220-2230.
15. Dalle, S.; Longuet, C.; Costes, S.; Broca, C.; Faruque, O.; Fontes, G.; Hani, E.H.; Bataille, D. Glucagon promotes cAMP-response element-binding protein phosphorylation via activation of ERK1/2in MIN6 cell line and isolated islets of Langerhans. J. Biol. Chem.,2004, 279(19), 20345-20355.
16. Jhala, U.S.; Canettieri, G.; Screaton, R.A.; Kulkarni, R.N.; Krajewski, S.; Reed, J.; Walker, J.; Lin, X.; White, M.; Montminy, M. cAMP promotes pancreatic beta-cell survival via CREB mediated induction of IRS2. Genes Dev., 2003, 17(13), 1575-1580.
17. Liu, W.; Chin-Chance, C.; Lee, E.J.; Lowe, W.L. Jr. Activation ofphosphatidylinositol 3-kinase contributes to insulin-like growth factor I-mediated inhibition of pancreatic beta-cell death. Endocrinology, 2002, 143(10), 3802-3812.
18. McIntosh, C.H.; Widenmaier, S.; Kim, S.J. Glucose-dependent insulinotropic polypeptide (Gastric Inhibitory Polypeptide; GIP).Vitam. Horm., 2009, 80, 409-471.
19. Withers, D.J.; Gutierrez, J.S.; Towery, H.; Burks, D.J.; Ren, J.M.; Previs, S.; Zhang, Y.; Bernal, D.; Pons, S.; Shulman, G.I.; Bonner-Weir, S.; White, M.F. Disruption of IRS-2 causes type 2 diabetes in mice. Nature, 1998, 391(6670), 900-904.
20. Kim, S.J.; Nian, C.; Widenmaier, S.; McIntosh, C.H. Glucose dependent insulinotropic polypeptide-mediated up-regulation ofbeta-cell antiapoptotic Bcl-2 gene expression is coordinated bycyclic AMP (cAMP) response element binding protein (CREB) andcAMP-responsive CREB coactivator 2. Mol. Cell. Biol., 2008,28(5), 1644-1656.
21. Jambal, P.; Masterson, S.; Nesterova, A.; Bouchard, R.; Bergman, B.; Hutton, J.C.; Boxer, L.M.; Reusch, J.E.; Pugazhenthi, S. Cytokine-mediated down-regulation of the transcription factor cAMP-response element-binding protein in pancreatic beta-cells. J.Biol. Chem., 2003, 278(25), 23055-23065.
22. Sarkar, S.A.; Gunter, J.; Bouchard, R.; Reusch, J.E.; Wiseman, A.; Gill, R.G.; Hutton, J.C.; Pugazhenthi, S. Dominant negative mutant forms of the cAMP response element binding protein induce apoptosis and decrease the anti-apoptotic action of growth factorsin human islets. Diabetologia, 2007, 50(8), 1649-1659.
23. Costes, S.; Vandewalle, B.; Tourrel-Cuzin, C.; Broca, C.; Linck, N.; Bertrand, G.; Kerr-Conte, J.; Portha, B.; Pattou, F.; Bockaert, J.; Dalle, S. Degradation of cAMP-responsive element-bindingprotein by the ubiquitin-proteasome pathway contributes toglucotoxicity in beta-cells and human pancreatic islets. Diabetes,2009, 58(5), 1105-1115.
24. West, A.E.; Chen, W.G.; Dalva, M.B.; Dolmetsch, R.E.; Kornhauser, J.M.; Shaywitz, A.J.; Takasu, M. A.; Tao, X.; Greenberg, M.E. Calcium regulation of neuronal gene expression. Proc. Natl. Acad. Sci. USA, 2001, 98(20), 11024-11031.
25. Mayer, S.I.; Thiel, G. Calcium influx into MIN6 insulinoma cells induces expression of Egr-1 involving extra cellular signal regulated protein kinase and the transcription factors Elk-1 andCREB. Eur. J. Cell. Biol., 2009, 88(1), 19-33.
26. Oetjen, E.; Lechleiter, A.; Blume, R.; Nihalani, D.; Holzman, L.; Knepel, W. Inhibition of membrane depolarisation-induced transcriptional activity of cyclic AMP response element binding protein (CREB) by the dual-leucine-zipper-bearing kinase in a pancreatic islet beta cell line. Diabetologia, 2006, 49(2), 332-342.
27. Henquin, J.C. Regulation of insulin secretion: a matter of phase control and amplitude modulation. Diabetologia, 2009, 52(5), 739-751.
28. Henquin, J.C.; Ravier, M.A.; Nenquin, M.; Jonas, J.C.; Gilon, P. Hierarchy of the beta-cell signals controlling insulin secretion. Eur.J. Clin. Invest., 2003, 33(9), 742-750.
29. Matschinsky, F.M. Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes, 1996, 45(2), 223-241.
30. Costes, S.; Longuet, C.; Broca, C.; Faruque, O.; Hani, E.H.; Bataille, D.; Dalle, S. Cooperative effects between protein kinase A and p44/p42 mitogen-activated protein kinase to promote cAMP responsive element binding protein activation after beta cell stimulation by glucose and its alteration due to glucotoxicity. Ann.NY Acad. Sci., 2004, 1030, 230-242.
31. Wang, O.; Cai, K.; Pang, S.; Wang, T.; Qi, D.; Zhu, Q.; Ni, Z.; Le, Y. Mechanisms of glucose-induced expression of pancreatic derived factor in pancreatic beta-cells. Endocrinology, 2008,149(2), 672-680.
32. Briaud, I.; Lingohr, M.K.; Dickson, L.M.; Wrede, C.E.; Rhodes, C.J. Differential activation mechanisms of Erk-1/2 and p70(S6K)by glucose in pancreatic beta-cells. Diabetes, 2003, 52(4), 974-983.
33. Li, X.Y.; Zhan, X.R.; Liu, X.M.; Wang, X.C. CREB is a regulatory target for the protein kinase Akt/PKB in the differenciation of pancreatic ductal cells into islet β-cells mediated by hepatocyte growth factor. Biochem. Biophys. Res. Commun., 2011, 404(2),711-716.
34. Liew, C.W.; Bochenski, J.; Kawamori, D.; Hu, J.; Leech, C.A.; Wanic, K.; Malecki, M.; Warram, J.H.; Qi, L.; Krolewski, A.S.; Kulkarni, R.N. The pseudokinase tribbles homolog 3 interacts withATF4 to negatively regulate insulin exocytosis in human and mouse beta cells. J. Clin. Invest., 2010, 120(8), 2876-2888.
35. Screaton, R.A.; Conkright, M.D.; Katoh, Y.; Best, J.L.; Canettieri, G.; Jeffries, S.; Guzman, E.; Niessen, S.; Yates, J.R. 3rd; Takemori, H.; Okamoto, M.; Montminy, M. The CREB coactivator TORC2functions as a calcium- and cAMP-sensitive coincidence detector.Cell, 2004, 119(1), 61-74.
36. Jansson, D.; Ng, A.C.; Fu, A.; Depatie, C.; Al Azzabi, M.; Screaton, R.A. Glucose controls CREB activity in islet cells via regulated phosphorylation of TORC2. Proc. Natl. Acad. Sci. USA,2008, 105(29), 10161-10166.
37. Robertson, R.P. Chronic oxidative stress as a central mechanismfor glucose toxicity in pancreatic islet beta cells in diabetes. J. Biol.Chem., 2004, 279(41), 42351-42354.
38. Hershko, A.; Ciechanover, A. The ubiquitin system. Annu. Rev.Biochem., 1998, 67, 425-479.
39. Kawaguchi, M.; Minami, K.; Nagashima, K.; Seino, S. Essentialrole of ubiquitin-proteasome system in normal regulation of insulin secretion. J. Biol. Chem., 2006, 281(19), 13015-13020.
40. Kitiphongspattana, K.; Mathews, C.E.; Leiter, E.H.; Gaskins, H.R. Proteasome inhibition alters glucose-stimulated (pro)insulin secretion and turnover in pancreatic beta-cells. J. Biol. Chem.,2005, 280(16), 15727-15734.
41. Lopez-Avalos, M.D.; Duvivier-Kali, V.F.; Xu, G.; Bonner-Weir, S.; Sharma, A.; Weir, G.C. Evidence for a role of the ubiquitin-protea some pathway in pancreatic islets. Diabetes, 2006, 55(5),1223-1231.
42. Briaud, I.; Dickson, L.M.; Lingohr, M.K.; McCuaig, J.F.; Lawrence, J.C.; Rhodes, C.J. Insulin receptor substrate-2proteasomal degradation mediated by a mammalian target o frapamycin (mTOR)-induced negative feedback down-regulates protein kinase B-mediated signaling pathway in beta-cells. J. Biol. Chem., 2005, 280(3), 2282-2293.
43. Harmon, J.S.; Stein, R.; Robertson, R.P. Oxidative stress-mediated, post-translational loss of MafA protein as a contributing mechanism to loss of insulin gene expression in glucotoxic beta cells. J. Biol. Chem., 2005, 280(12), 11107-11113.
44. Taylor, C.T.; Furuta, G.T.; Synnestvedt, K.; Colgan, S.P. Phosphorylation-dependent targeting of cAMP response element binding protein to the ubiquitin/proteasome pathway in hypoxia. Proc. Natl. Acad. Sci. USA, 2000, 97(22), 12091-12096.
45. Laney, J.D.; Hochstrasser, M. Substrate targeting in the ubiquitin system. Cell, 1999, 97(4), 427-430.
46. Bockaert, J.; Pin, J.P. Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J., 1999, 18(7), 1723-1729.
47. Mayo, K.E.; Miller, L.J.; Bataille, D.; Dalle, S.; Goke, B.; Thorens, B.; Drucker, D.J. International Union of Pharmacology. XXXV.The glucagon receptor family. Pharmacol. Rev., 2003, 55(1), 167-194.
48. Pantaloni, C.; Brabet, P.; Bilanges, B.; Dumuis, A.; Houssami, S.; Spengler, D.; Bockaert, J.; Journot, L. Alternative splicing in the Nterminal extracellular domain of the pituitary adenylate cyclase activating polypeptide (PACAP) receptor modulates receptors electivity and relative potencies of PACAP-27 and PACAP-38 inphospholipase C activation. J. Biol. Chem., 1996, 271(36), 22146-22151.
49. Pin, J.P.; Bockaert, J. Get receptive to metabotropic glutamate receptors. Curr. Opin. Neurobiol., 1995, 5(3), 342-349.
50. Neves, S.R.; Ram, P.T.; Iyengar, R. G protein pathways. Science,2002, 296(5573), 1636-1639.
51. Sands, W.A.; Palmer, T.M. Regulating gene transcription in response to cyclic AMP elevation. Cell. Signal., 2008, 20(3), 460-466.
52. Doyle, M.E.; Egan, J.M. Mechanisms of action of glucagon-likepeptide 1 in the pancreas. Pharmacol. Ther., 2007, 113(3), 546-593.
53. Foord, S.M.; Bonner, T.I.; Neubig, R.R.; Rosser, E.M.; Pin, J.P.; Davenport, A.P.; Spedding, M.; Harmar, A.J. International Union of Pharmacology. XLVI. G protein-coupled receptor list. Pharmacol. Rev., 2005, 57(2), 279-288.
54. Drucker, D.J. The biology of incretin hormones. Cell. Metab.,2006, 3(3), 153-165.
55. Wang, X.; Zhou, J.; Doyle, M.E.; Egan, J.M. Glucagon-likepeptide-1 causes pancreatic duodenal homeobox-1 protein translocation from the cytoplasm to the nucleus of pancreatic beta cells by a cyclic adenosine monophosphate/protein kinase A dependent mechanism. Endocrinology, 2001, 142(5), 1820-1827.
56. Holz, G.G. Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell. Diabetes, 2004, 53(1), 5-13.
57. Kang, J.H.; Kim, M.J.; Jang, H.I.; Koh, K.H.; Yum, K.S.; Rhie, D.J.; Yoon, S.H.; Hahn, S.J.; Kim, M. S.; Jo, Y.H. Proximal cyclicAMP response element is essential for exendin-4 induction of ratEGR-1 gene. Am. J. Physiol. Endocrinol. Metab., 2007, 292(1),E215-222.
58. Kim, M.J.; Kang, J.H.; Park, Y.G.; Ryu, G.R.; Ko, S.H.; Jeong, I.K.; Koh, K.H.; Rhie, D.J.; Yoon, S. H.; Hahn, S.J.; Kim, M.S.; Jo, Y.H. Exendin-4 induction of cyclin D1 expression in INS-1 beta cells: involvement of cAMP-responsive element. J. Endocrinol.,2006, 188(3), 623-633.
59. Song, W.J.; Schreiber, W.E.; Zhong, E.; Liu, F.F.; Kornfeld, B.D.; Wondisford, F.E.; Hussain, M.A. Exendin-4 stimulation of cyclinA2 in beta-cell proliferation. Diabetes, 2008, 57(9), 2371-2381.
60. Klinger, S.; Poussin, C.; Debril, M.B.; Dolci, W.; Halban, P.A.; Thorens, B. Increasing GLP-1-induced beta-cell proliferation by silencing the negative regulators of signaling cAMP response element modulator-alpha and DUSP14. Diabetes, 2008, 57(3), 584-593.
61. Kim, S.J.; Nian, C.; McIntosh, C.H. Glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 modulate beta-cell chromatin structure. J. Biol. Chem., 2009, 284(19),12896-12904.
62. Tan, C.; Salehi, A.; Svensson, S.; Olde, B.; Erlinge, D. ADP receptor P2Y(13) induce apoptosis in pancreatic beta-cells. Cell.Mol. Life Sci., 2010, 67(3), 445-453.
63. Nishizuka, Y. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J., 1995, 9(7), 484-496.
64. Won, J.G.; Orth, D.N. Role of lipoxygenase metabolites of arachidonic acid in the regulation of adrenocorticotropin secretionby perifused rat anterior pituitary cells. Endocrinology, 1994,135(4), 1496-1503.
65. Enslen, H.; Sun, P.; Brickey, D.; Soderling, S.H.; Klamo, E.; Soderling, T.R. Characterization of Ca2+/calmodulin-dependentprotein kinase IV. Role in transcriptional regulation. J. Biol. Chem.,1994, 269(22), 15520-15527.
66. Sheng, M.; Thompson, M.A.; Greenberg, M.E. CREB: a Ca(2+)-regulated transcription factor phosphorylated by calmodul independent kinases. Science, 1991, 252(5011), 1427-1430.
67. Matthews, R.P.; Guthrie, C.R.; Wailes, L.M.; Zhao, X.; Means, A.R.; McKnight, G.S. Calcium/calmodulin-dependent protein kinase types II and IV differentially regulate CREB-dependent gene expression. Mol. Cell. Biol., 1994, 14(9), 6107-6116.
68. Wu, X.; McMurray, C.T. Calmodulin kinase II attenuation of gene transcription by preventing cAMP response element-binding protein (CREB) dimerization and binding of the CREB-binding protein. J. Biol. Chem., 2001, 276(3), 1735-1741.
69. Kulkarni, R.N.; Holzenberger, M.; Shih, D.Q.; Ozcan, U.; Stoffel, M.; Magnuson, M.A.; Kahn, C.R. beta-cell-specific deletion of theIgf1 receptor leads to hyper insulinemia and glucose intolerance but does not alter beta-cell mass. Nat. Genet., 2002, 31(1), 111-115.
70. Lefkowitz, R.J.; Shenoy, S.K. Transduction of receptor signals by beta-arrestins. Science, 2005, 308(5721), 512-517.
71. Ma, L.; Pei, G. Beta-arrestin signaling and regulation of transcription. J. Cell. Sci., 2007, 120(Pt. 2), 213-218.
72. Kang, J.; Shi, Y.; Xiang, B.; Qu, B.; Su, W.; Zhu, M.; Zhang, M.; Bao, G.; Wang, F.; Zhang, X.; Yang, R.; Fan, F.; Chen, X.; Pei, G.; Ma, L. A nuclear function of beta-arrestin1 in GPCR signaling: regulation of histone acetylation and gene transcription. Cell, 2005,123(5), 833-847.
73. Sonoda, N.; Imamura, T.; Yoshizaki, T.; Babendure, J.L.; Lu, J.C.; Olefsky, J.M. Beta-Arrestin-1 mediates glucagon-like peptide-1signaling to insulin secretion in cultured pancreatic beta cells. Proc.Natl. Acad. Sci. USA, 2008, 105(18), 6614-6619.